Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/22849
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorTEIXEIRA, Priscila Camillo-
dc.contributor.authorSANTOS, Ronaldo Honorato Barros-
dc.contributor.authorFIORELLI, Alfredo Inacio-
dc.contributor.authorBILATE, Angelina Morand Bianchi-
dc.contributor.authorBENVENUTI, Luiz Alberto-
dc.contributor.authorSTOLF, Noedir Antonio-
dc.contributor.authorKALIL, Jorge-
dc.contributor.authorCUNHA-NETO, Edecio-
dc.date.accessioned2017-11-27T16:24:53Z-
dc.date.available2017-11-27T16:24:53Z-
dc.date.issued2011-
dc.identifier.citationPLOS NEGLECTED TROPICAL DISEASES, v.5, n.6, article ID e1205, 9p, 2011-
dc.identifier.issn1935-2727-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/22849-
dc.description.abstractBackground: Chronic Chagas disease cardiomyopathy (CCC) is an inflammatory dilated cardiomyopathy with a worse prognosis than other cardiomyopathies. CCC occurs in 30 % of individuals infected with Trypanosoma cruzi, endemic in Latin America. Heart failure is associated with impaired energy metabolism, which may be correlated to contractile dysfunction. We thus analyzed the myocardial gene and protein expression, as well as activity, of key mitochondrial enzymes related to ATP production, in myocardial samples of end-stage CCC, idiopathic dilated (IDC) and ischemic (IC) cardiomyopathies. Methodology/Principal Findings: Myocardium homogenates from CCC (N = 5), IC (N = 5) and IDC (N = 5) patients, as well as from heart donors (N = 5) were analyzed for protein and mRNA expression of mitochondrial creatine kinase (CKMit) and muscular creatine kinase (CKM) and ATP synthase subunits aplha and beta by immunoblotting and by real-time RT-PCR. Total myocardial CK activity was also assessed. Protein levels of CKM and CK activity were reduced in all three cardiomyopathy groups. However, total CK activity, as well as ATP synthase alpha chain protein levels, were significantly lower in CCC samples than IC and IDC samples. CCC myocardium displayed selective reduction of protein levels and activity of enzymes crucial for maintaining cytoplasmic ATP levels. Conclusions/Significance: The selective impairment of the CK system may be associated to the loss of inotropic reserve observed in CCC. Reduction of ATP synthase alpha levels is consistent with a decrease in myocardial ATP generation through oxidative phosphorylation. Together, these results suggest that the energetic deficit is more intense in the myocardium of CCC patients than in the other tested dilated cardiomyopathies.-
dc.description.sponsorshipBrazilian Council for Scientific and Technological Development - CNPq-
dc.description.sponsorshipSao Paulo State Research Funding Agency - FAPESP-
dc.language.isoeng-
dc.publisherPUBLIC LIBRARY SCIENCE-
dc.relation.ispartofPlos Neglected Tropical Diseases-
dc.rightsopenAccess-
dc.subject.otheridiopathic dilated cardiomyopathy-
dc.subject.othermitochondrial respiratory-chain-
dc.subject.othertrypanosoma-cruzi infection-
dc.subject.otherheart-failure-
dc.subject.otherischemia-reperfusion-
dc.subject.otherenergy-metabolism-
dc.subject.othercardiac disease-
dc.subject.othernitric-oxide-
dc.subject.othermyocarditis-
dc.subject.otherexpression-
dc.titleSelective Decrease of Components of the Creatine Kinase System and ATP Synthase Complex in Chronic Chagas Disease Cardiomyopathy-
dc.typearticle-
dc.rights.holderCopyright PUBLIC LIBRARY SCIENCE-
dc.identifier.doi10.1371/journal.pntd.0001205-
dc.identifier.pmid21738806-
dc.subject.wosInfectious Diseases-
dc.subject.wosParasitology-
dc.subject.wosTropical Medicine-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalBILATE, Angelina Morand Bianchi:Univ Sao Paulo, Sch Med, Immunol Lab, Inst Heart, Sao Paulo, Brazil-
hcfmusp.description.articlenumbere1205-
hcfmusp.description.issue6-
hcfmusp.description.volume5-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000292139600041-
hcfmusp.origem.id2-s2.0-79959843202-
hcfmusp.publisher.citySAN FRANCISCO-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAbel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523-
hcfmusp.relation.referenceSpindler M, 2004, AM J PHYSIOL-HEART C, V287, pH1039, DOI 10.1152/ajpheart.01016.2003-
hcfmusp.relation.referenceSilva CP, 2008, ARQ BRAS CARDIOL, V91, P358-
hcfmusp.relation.referenceBocchi EA, 2001, ANN THORAC SURG, V71, P1833, DOI 10.1016/S0003-4975(01)02587-5-
hcfmusp.relation.referenceLygate CA, 2007, J MOL CELL CARDIOL, V42, P1129, DOI 10.1016/j.yjmcc.2007.03.899-
hcfmusp.relation.referenceKALOVIDOURIS AE, 1993, J RHEUMATOL, V20, P1718-
hcfmusp.relation.referenceJarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0-
hcfmusp.relation.referenceSchmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73-
hcfmusp.relation.referenceAcquatella H, 1999, J AM COLL CARDIOL, V33, P522, DOI 10.1016/S0735-1097(98)00569-5-
hcfmusp.relation.referenceLiao RL, 1996, CIRC RES, V78, P893-
hcfmusp.relation.referenceSchofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011-
hcfmusp.relation.referenceMURRY CE, 1990, CIRC RES, V66, P913-
hcfmusp.relation.referenceWeiss RG, 2005, P NATL ACAD SCI USA, V102, P808, DOI 10.1073/pnas.0408962102-
hcfmusp.relation.referenceGarg N, 2003, BBA-MOL BASIS DIS, V1638, P106, DOI 10.1016/S0925-4439(03)00060-7-
hcfmusp.relation.referenceNascimben L, 1996, CIRCULATION, V94, P1894-
hcfmusp.relation.referenceBestetti RB, 1997, INT J CARDIOL, V60, P187, DOI 10.1016/S0167-5273(97)00083-1-
hcfmusp.relation.referenceMADY C, 1994, CIRCULATION, V90, P3098-
hcfmusp.relation.referenceVyatkina G, 2004, BBA-MOL BASIS DIS, V1689, P162, DOI 10.1016/j.bbadis.2004.03.005-
hcfmusp.relation.referenceLesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378-
hcfmusp.relation.referenceVentura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095-
hcfmusp.relation.referenceSchaub MC, 1997, J MOL MED-JMM, V75, P901, DOI 10.1007/s001090050182-
hcfmusp.relation.referenceBilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001-
hcfmusp.relation.referenceBocchi E A, 1994, Arq Bras Cardiol, V63, P523-
hcfmusp.relation.referenceBowling J, 2009, EXPERT REV ANTI-INFE, V7, P1223, DOI [10.1586/eri.09.107, 10.1586/ERI.09.107]-
hcfmusp.relation.referenceCarvajal K, 2003, ARCH MED RES, V34, P89, DOI 10.1016/S0188-4409(03)00004-3-
hcfmusp.relation.referenceCORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812-
hcfmusp.relation.referenceCunha-Neto E, 2001, AUTOIMMUNITY, V34, P187, DOI 10.3109/08916930109007383-
hcfmusp.relation.referenceCunha-Neto E, 2005, AM J PATHOL, V167, P305, DOI 10.1016/S0002-9440(10)62976-8-
hcfmusp.relation.referenceLARANJA FS, 1956, CIRCULATION, V14, P1035-
hcfmusp.relation.referenceDias J C, 2000, Cad Saude Publica, V16 Suppl 2, P43-
hcfmusp.relation.referenceGomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003-
hcfmusp.relation.referenceHIGUCHI MD, 1987, CLIN CARDIOL, V10, P665-
hcfmusp.relation.referenceINGWALL JS, 1982, AM J PHYSIOL, V242, pH729-
hcfmusp.relation.referenceINGWALL JS, 1990, EUR HEART J, V11, P108-
hcfmusp.relation.referenceLUSS H, 1995, J MOL CELL CARDIOL, V27, P2015, DOI 10.1016/0022-2828(95)90023-3-
hcfmusp.relation.referenceMarin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296-
hcfmusp.relation.referenceNahrendorf M, 2005, CARDIOVASC RES, V65, P419, DOI 10.1016/j.cardiores.2004.10.006-
hcfmusp.relation.referenceNeubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052-
hcfmusp.relation.referenceNing XH, 2000, J AM COLL CARDIOL, V36, P282, DOI 10.1016/S0735-1097(00)00689-6-
hcfmusp.relation.referenceBARRETTO ACP, 1986, AM HEART J, V111, P307, DOI 10.1016/0002-8703(86)90144-4-
hcfmusp.relation.referenceQuigley AF, 2000, J CARD FAIL, V6, P47, DOI 10.1016/S1071-9164(00)00011-7-
hcfmusp.relation.referenceReis MM, 1997, CLIN IMMUNOL IMMUNOP, V83, P165, DOI 10.1006/clin.1997.4335-
hcfmusp.relation.referenceTEIXEIRA ARL, 1990, J INFECT DIS, V162, P1420-
hcfmusp.relation.referenceTeixeira PC, 2006, BRAZ J MED BIOL RES, V39, P1549, DOI 10.1590/S0100-879X2006001200005-
hcfmusp.relation.referenceTian R, 1996, J MOL CELL CARDIOL, V28, P755, DOI 10.1006/jmcc.1996.0070-
hcfmusp.relation.referenceWang DC, 1996, LAB INVEST, V75, P809-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus24-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - FM/MCP
Departamento de Cardio-Pneumologia - FM/MCP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/11
LIM/11 - Laboratório de Cirurgia Cardiovascular e Fisiopatologia da Circulação

Artigos e Materiais de Revistas Científicas - LIM/19
LIM/19 - Laboratório de Histocompatibilidade e Imunidade Celular


Files in This Item:
File Description SizeFormat 
art_TEIXEIRA_Selective_Decrease_of_Components_of_the_Creatine_Kinase_2011.PDFpublishedVersion (English)980.38 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.